Is MRZM or BTI a better dividend investment in 2026?

MRZM currently yields 666666.67% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: MRZM offers higher current income.

What is the dividend yield difference between MRZM and BTI?

MRZM has a forward dividend yield of 666666.67% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 666661.29 percentage points.

Home › Compare › MRZM vs BTI

MRZM vs BTI: Dividend Comparison 2026

MRZM yields 666666.67% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MRZM wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MRZM

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full MRZM calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — MRZM vs BTI

📍 MRZM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MRZM	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MRZM + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MRZM pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRZM

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, MRZM beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRZM + BTI for your $10,000?

MRZM: 50%BTI: 50%

100% BTI50/50100% MRZM

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

MRZM

No analyst data

Altman Z

-14.7

Piotroski

3/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRZM buys

BTI buys

No recent congressional trades found for MRZM or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMRZMBTI

Forward yield	666666.67% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$8.275235618773884e+34M	$37.7K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$2,786.64
Total dividends collected	$8.275075881065991e+34M	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: MRZM vs BTI ($10,000, DRIP)

Year	MRZM Portfolio	MRZM Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$11,299	$598.92	+$66.67M → MRZM
2	$415,506,651,117	$415,435,306,334.37	$12,794	$703.91	+$415506.64M → MRZM
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$14,518	$829.07	+$2419908598.37M → MRZM
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$16,513	$978.64	+$13171697643084.44M → MRZM
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$18,827	$1,157.84	+$67004927492790120.00M → MRZM
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$21,518	$1,373.12	+$318562277003514871808.00M → MRZM
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$24,657	$1,632.46	+$1.415484168853553e+24M → MRZM
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$28,329	$1,945.74	+$5.878130573362507e+27M → MRZM
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$32,637	$2,325.33	+$2.2813793009840744e+31M → MRZM
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$37,708	$2,786.64	+$8.275235618773884e+34M → MRZM

MRZM vs BTI: Complete Analysis 2026

MRZM — Stock

Marizyme, Inc., a life science company, engages in the development and commercialization of medical technologies business. It offers DuraGraft, a one-time intraoperative vascular graft treatment for use in vascular and bypass surgeries that maintains endothelial function and structure, and other related properties. The company also develops various products using its Krillase protease-based therapeutic platform for treating complex wounds and burns, acute ischemic stroke, deep vein thrombosis, and dissolving plaque and biofilms on teeth. In addition, it focuses on developing products to mitigate the effects of ischemia reperfusion injury in other grafting and transplantation surgeries, and other indications. Further, it is involved in developing MATLOC, a point-of-care, lab-on-chip digital screening and diagnostic device platform for chronic kidney disease assessment. The company was formerly known as GBS Enterprises Incorporated. Marizyme, Inc. was incorporated in 2007 and is based in Jupiter, Florida.

Full MRZM Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this MRZM vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRZM vs SCHD MRZM vs JEPI MRZM vs O MRZM vs KO MRZM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.